CorVista Health Appoints Nikki Troiano Gainey as Chief Customer Officer and Names Ian Shadforth Chief Strategy Officer
CorVista Health today announced the appointment of Nikki Troiano Gainey as Chief Customer Officer. In this role, Gainey will lead CorVista's customer strategy, commercial execution, and market development, as the company expands adoption of the CorVista System, a non-invasive, point-of-care platform designed to support cardiovascular disease detection and clinical decision-making. As part of the leadership transition, Ian Shadforth has been appointed to the role of Chief Strategy Officer, where he will focus on enterprise strategy, strategic partnerships, and long-term growth initiatives for CorVista.
CorVista Health Announces Collaboration with Mayo Clinic to Advance Next-Gen Pulmonary Hypertension Diagnosis
CorVista Health has announced a research collaboration with Mayo Clinic to evaluate how next-generation, non-invasive diagnostics may transform the identification and management of pulmonary hypertension (PH) – a complex and frequently underdiagnosed cardiovascular condition that affects an estimated one percent of the global population.
CorVista Health Demonstrates High-Sensitivity for Noninvasive Detection of CAD including INOCA (Ischemia with No Obstructed Coronary Arteries) at ACC.26
CorVista Health, a leader in noninvasive cardiovascular diagnostics, today announced new data evaluating a physiologic signal–based machine-learning model for detecting cardiac ischemia. The data was presented at the American College of Cardiology’s Annual Scientific Session (ACC.26), taking place March 28–30, 2026 in New Orleans.
CorVista Health to Present New Data on Non-Invasive Point of Care Test for Ischemia with Non-Obstructive Coronary Arteries Using Machine Learning at ACC.26
CorVista Health today announced the upcoming poster presentation of new data on its non-invasive point of care test for ischemia with non-obstructive coronary arteries (INOCA) – a common condition, particularly in women, where patients experience cardiovascular symptoms despite having no flow-limiting blockages in their major epicardial arteries – using machine learning at the American College of Cardiology’s Annual Scientific Session (ACC.26), taking place March 28-30, 2026, in New Orleans, LA.
CorVista Health Named MedTech Outlook Editor's Choice for MedTech Startup for 2023
CorVista Health, Inc, a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce that it has been honored with the Editor’s Choice designation as the Top MedTech Startup for 2023 by MedTech Outlook.
Charles R. Bridges, M.D., Sc.D., Elected to the National Academy of Engineering Membership
CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the election of Dr. Charles Bridges to the National Academy of Engineering (NAE). In addition to Dr. Bridges, NAE President John L. Anderson announced 132 new members for 2022, bringing the total U.S. membership to 2,388 and international to 310.
